BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 21040551)

  • 21. Cell cycle-dependent chromatin shuttling of HBO1-JADE1 histone acetyl transferase (HAT) complex.
    Siriwardana NS; Meyer R; Havasi A; Dominguez I; Panchenko MV
    Cell Cycle; 2014; 13(12):1885-901. PubMed ID: 24739512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel non-coding RNA lncRNA-JADE connects DNA damage signalling to histone H4 acetylation.
    Wan G; Hu X; Liu Y; Han C; Sood AK; Calin GA; Zhang X; Lu X
    EMBO J; 2013 Oct; 32(21):2833-47. PubMed ID: 24097061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cells.
    Duong MT; Akli S; Macalou S; Biernacka A; Debeb BG; Yi M; Hunt KK; Keyomarsi K
    Cancer Res; 2013 Sep; 73(17):5556-68. PubMed ID: 23955388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization, polymorphism and association of porcine MYST2 gene.
    Yong WJ; Jing L; Jiugang Z; Lei C; Yonggang L
    Mol Biol Rep; 2012 Jul; 39(7):7711-6. PubMed ID: 22327654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen receptor α (ERα) mediates 17β-estradiol (E2)-activated expression of HBO1.
    Wang WZ; Liu HO; Wu YH; Hong Y; Yang JW; Liu YH; Wu WB; Zhou L; Sun LL; Xu JJ; Yun XJ; Gu JX
    J Exp Clin Cancer Res; 2010 Nov; 29(1):140. PubMed ID: 21040551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrinsic ubiquitin E3 ligase activity of histone acetyltransferase Hbo1 for estrogen receptor α.
    Iizuka M; Susa T; Tamamori-Adachi M; Okinaga H; Okazaki T
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(7):498-510. PubMed ID: 28769019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of ClC-3 chloride channel by 17β-estradiol relies on the estrogen receptor α expression in breast cancer.
    Yang H; Ma L; Wang Y; Zuo W; Li B; Yang Y; Chen Y; Chen L; Wang L; Zhu L
    J Cell Physiol; 2018 Feb; 233(2):1071-1081. PubMed ID: 28419445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone acetyltransferase Hbo1 destabilizes estrogen receptor α by ubiquitination and modulates proliferation of breast cancers.
    Iizuka M; Susa T; Takahashi Y; Tamamori-Adachi M; Kajitani T; Okinaga H; Fukusato T; Okazaki T
    Cancer Sci; 2013 Dec; 104(12):1647-55. PubMed ID: 24125069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
    Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
    FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells.
    Oh AS; Lorant LA; Holloway JN; Miller DL; Kern FG; El-Ashry D
    Mol Endocrinol; 2001 Aug; 15(8):1344-59. PubMed ID: 11463858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histone acetyltransferase Hbo1: catalytic activity, cellular abundance, and links to primary cancers.
    Iizuka M; Takahashi Y; Mizzen CA; Cook RG; Fujita M; Allis CD; Frierson HF; Fukusato T; Smith MM
    Gene; 2009 May; 436(1-2):108-14. PubMed ID: 19393168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic alterations and oncogenic pathways associated with breast cancer subtypes.
    Hu X; Stern HM; Ge L; O'Brien C; Haydu L; Honchell CD; Haverty PM; Peters BA; Wu TD; Amler LC; Chant J; Stokoe D; Lackner MR; Cavet G
    Mol Cancer Res; 2009 Apr; 7(4):511-22. PubMed ID: 19372580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repression of estrogen receptor alpha by CDK11p58 through promoting its ubiquitin-proteasome degradation.
    Wang Y; Zong H; Chi Y; Hong Y; Yang Y; Zou W; Yun X; Gu J
    J Biochem; 2009 Mar; 145(3):331-43. PubMed ID: 19122208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HBO1 histone acetylase is a coactivator of the replication licensing factor Cdt1.
    Miotto B; Struhl K
    Genes Dev; 2008 Oct; 22(19):2633-8. PubMed ID: 18832067
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.